Parkinson's Disease Trial, Not Yet Recruiting NCT07190235 Sponsor: The Hong Kong Polytechnic University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT07190235
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Parkinson's disease according to the standards set by the Movement Disorder Committee.
  • People whose Parkinson's disease is at a mild to moderate stage, known as Hoehn and Yahr stages II or III.
  • People who report having difficulty starting to walk, as measured by a specific question on a recognised freezing of gait questionnaire.
  • People who have been taking a Parkinson's-related medication (dopaminergic medication) within the last month.
  • People who score at least 23 out of 30 on a standard thinking and memory test called the Montreal Cognitive Assessment (MoCA).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have unstable medical conditions.
  • People who are unable to give informed consent to participate.
  • People who have other neurological conditions, including stroke.
  • People who have a medical reason that would make a brain stimulation technique called TMS unsafe for them (confirm with trial site).
  • People who have previously had deep brain stimulation treatment.
  • People in whom a specific type of brain response called a motor evoked potential (MEP) cannot be detected when TMS is used (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +852 27664676

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
The Hong Kong Polytechnic University
Registry
ClinicalTrials.gov
Start date
6 January 2026
Est. completion
30 April 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

Change in duration of anticipatory postural adjustments (APAs) during gait initiation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov